Comment by
Rumpl3StiltSkin on Jun 29, 2023 8:08pm
With the BCG shortage and lack of anything even close, sorry Keytruda, It would seem 1433 would be granted AA?
Comment by
Jaro1977 on Jun 29, 2023 8:44pm
Roger expined that we have to go through all the steps, no cutting corners, BTD and AA will move us through the line faster but no stages can be skipped
Comment by
Rumpl3StiltSkin on Jun 29, 2023 9:52pm
Well that is interesting, If that was stated it sounds like what some here have been thinking lately. First we get BTD, then apply for AA. The numbers are good enough. Final FDA approval won't come until study 2 is complete. But AA could happen some time after they are granted BTD. At least that is what I've been thinking.
Comment by
ScienceFirst on Jun 29, 2023 10:11pm
AA has always been after BTD. TLT will also qualify for Priority Review, shaving another 6 months to market. AA will allow us to charge for treatment, so to cover our cost and more.
Comment by
stocksnbonds458 on Jul 02, 2023 2:46pm
Science, in my opinion AA provides us with the 30 pound sledgehammer required for negotiations with big pharma, and I don't mean a JV. I mean a buyout. Remember, JV= , Buyout =
Comment by
DeathXray33 on Jul 03, 2023 12:20pm
Osmium 1829; colon cancer... I buy every week no matter the price... >1.072 mil
Comment by
Rumpl3StiltSkin on Jul 04, 2023 2:29pm
Good job! And, BC great point. Colon Cancer is going to be big for TLT.
Comment by
Dumbledorf on Jul 03, 2023 12:44pm
This post has been removed in accordance with Community Policy